title: The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERalpha-mediated transcriptional responses.
abstract: The estrogen response element (ERE) consensus sequence is AGGTCAnnnTGACCT, where nnn is known as the tri-nucleotide spacer sequence. Studying 1017 high-confidence ERalpha-bound loci, we found that genomic EREs are enriched for spacers composed of C(A/T)G, suggesting that the spacer may influence receptor binding and transcriptional responses. We designed consensus EREs containing variable spacer sequences and compared ERalpha binding in gel shift assays and enhancer function in reporter assays. We found that ERalpha-ERE binding affinity is modulated by the tri-nucleotide spacer sequence and is favored by spacer sequences of CTG>GCC>TTT. Similarly, luciferase reporter assays indicated that the estrogen-stimulated transcriptional response is modulated by the spacer and parallels the gel shift data: CTG>GCC>TTT. Reporter assays demonstrated that the spacer sequence also modulates the sensitivity of EREs to repression engendered by the receptor antagonist hydroxytamoxifen. These experiments indicate that the sequence of the tri-nucleotide spacer is non-random at receptor-bound genomic loci, influences ERalpha-DNA-binding affinity, and modulates transactivation potential of the receptor-ligand-DNA complex. This work has implications for understanding which genomic EREs are targeted by ERalpha, should improve computational prediction of functional EREs within genomic sequences, and describes novel sequence determinants of the estrogen response.
authors.affiliation: Department of Gynecology and Obstetrics, Emory University School of Medicine, 1639 Pierce Drive, WMB 4217, Atlanta, GA 30322, USA.
authors.forename: Feng-Jue
authors.initials: FJ
authors.lastname: Shu
authors.forename: Neil
authors.initials: N
authors.lastname: Sidell
authors.forename: Danzhou
authors.initials: D
authors.lastname: Yang
authors.forename: Caleb B
authors.initials: CB
authors.lastname: Kallen
mesh_terms: D002460:Cell Line; D045744:Cell Line, Tumor; D047628:Estrogen Receptor alpha / Q000037:antagonists & inhibitors / Q000235:genetics*; D004967:Estrogens / Q000235:genetics*; D056426:Genetic Loci; D006801:Humans; D011485:Protein Binding; D020218:Response Elements; D014158:Transcription, Genetic
chemical_list: D047628:Estrogen Receptor alpha; D004967:Estrogens
references.citation: Endocrinology. 2003 Jun;144(6):2325-35
references.pmid: 12746293
references.citation: Mol Endocrinol. 2005 Apr;19(4):833-42
references.pmid: 15695368
references.citation: EMBO J. 2009 May 20;28(10):1418-28
references.pmid: 19339991
references.citation: Mol Endocrinol. 1996 Jun;10(6):694-704
references.pmid: 8776729
references.citation: Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11651-6
references.pmid: 16087863
references.citation: Science. 1991 Nov 22;254(5035):1210-4
references.pmid: 1957173
references.citation: Curr Protoc Bioinformatics. 2008 Mar;Chapter 2:Unit 2.6
references.pmid: 18428685
references.citation: Genome Res. 2009 Jun;19(6):967-77
references.pmid: 19246569
references.citation: Mol Endocrinol. 2007 Nov;21(11):2651-62
references.pmid: 17666587
references.citation: Mol Endocrinol. 1999 Oct;13(10):1672-85
references.pmid: 10517669
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: J Clin Oncol. 1992 Feb;10(2):304-10
references.pmid: 1732430
references.citation: Cell. 1993 Nov 5;75(3):567-78
references.pmid: 8221895
references.citation: Structure. 1993 Nov 15;1(3):187-204
references.pmid: 16100953
references.citation: J Biol Chem. 1998 Nov 6;273(45):29321-30
references.pmid: 9792632
references.citation: Mol Syst Biol. 2008;4:188
references.pmid: 18414489
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19199-204
references.pmid: 19052240
references.citation: Breast Cancer Res Treat. 2004 May;85(2):151-9
references.pmid: 15111773
references.citation: Mol Cell Biol. 1992 May;12(5):2037-42
references.pmid: 1569939
references.citation: J Mol Endocrinol. 2008 Nov;41(5):263-75
references.pmid: 18772268
references.citation: J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82
references.pmid: 1920493
references.citation: J Biol Chem. 2005 Jun 3;280(22):21491-7
references.pmid: 15790569
references.citation: Genes Dev. 2009 Jul 1;23(13):1522-33
references.pmid: 19515975
references.citation: J Biol Chem. 2001 Nov 30;276(48):45282-8
references.pmid: 11574541
references.citation: Cancer Res. 2008 May 1;68(9):3505-15
references.pmid: 18451179
references.citation: Mol Endocrinol. 2004 Aug;18(8):1859-75
references.pmid: 15031323
references.citation: J Steroid Biochem Mol Biol. 2008 May;110(1-2):104-15
references.pmid: 18400491
references.citation: Nat Genet. 2006 Nov;38(11):1289-97
references.pmid: 17013392
references.citation: PLoS One. 2008;3(10):e3523
references.pmid: 18949048
references.citation: Science. 2008 Jan 11;319(5860):202-6
references.pmid: 18187655
references.citation: Mol Endocrinol. 2001 Jul;15(7):1114-26
references.pmid: 11435612
references.citation: Science. 1997 Sep 5;277(5331):1508-10
references.pmid: 9278514
references.citation: Mol Endocrinol. 2004 Jun;18(6):1411-27
references.pmid: 15001666
references.citation: Nucleic Acids Res. 2001 Jul 15;29(14):2905-19
references.pmid: 11452016
references.citation: J Steroid Biochem Mol Biol. 1998 Oct;67(2):79-88
references.pmid: 9877207
references.citation: J Biol Chem. 2004 Feb 6;279(6):5025-34
references.pmid: 14617632
references.citation: Mol Endocrinol. 2008 Nov;22(11):2393-406
references.pmid: 18818283
references.citation: Mol Cell Biol. 2007 Jul;27(14):5090-104
references.pmid: 17515612
references.citation: Nucleic Acids Res. 1984 Nov 26;12(22):8611-26
references.pmid: 6504705
references.citation: J Mol Endocrinol. 2002 Aug;29(1):137-52
references.pmid: 12200235
references.citation: Endocr Relat Cancer. 2009 Jun;16(2):381-9
references.pmid: 19369485
references.citation: Endocrinology. 2004 May;145(5):2291-6
references.pmid: 14726435
references.citation: Genome Res. 2006 Aug;16(8):962-72
references.pmid: 16809671
references.citation: PLoS Genet. 2007 Jun;3(6):e87
references.pmid: 17542648
references.citation: Cell. 1998 Dec 23;95(7):927-37
references.pmid: 9875847
references.citation: Nucleic Acids Res. 2008 Jan;36(1):76-93
references.pmid: 17986456
references.citation: Nucleic Acids Res. 1988 Jan 25;16(2):647-63
references.pmid: 3340549
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4893-8
references.pmid: 11320240
references.citation: Trends Endocrinol Metab. 2004 Mar;15(2):73-8
references.pmid: 15036253
references.citation: Cancer Res. 2006 Jul 15;66(14):7334-40
references.pmid: 16849584
references.citation: Mol Endocrinol. 2005 Apr;19(4):843-54
references.pmid: 15637147
references.citation: Cell. 2005 Jul 15;122(1):33-43
references.pmid: 16009131
references.citation: Science. 2009 Jun 26;324(5935):1720-3
references.pmid: 19443739
references.citation: Mol Cell Biol. 1998 Apr;18(4):1927-34
references.pmid: 9528764
references.citation: Cold Spring Harb Symp Quant Biol. 1993;58:141-7
references.pmid: 7956024
references.citation: J Biol Chem. 1994 Jun 3;269(22):15912-7
references.pmid: 8195246
references.citation: Lancet. 1998 May 16;351(9114):1451-67
references.pmid: 9605801
references.citation: Clin Cancer Res. 2004 Apr 1;10(7):2336-43
references.pmid: 15073109
references.citation: J Biol Chem. 2007 Jun 15;282(24):17335-9
references.pmid: 17463000
references.citation: Endocr Rev. 2004 Feb;25(1):45-71
references.pmid: 14769827
references.citation: Mol Cell Endocrinol. 2001 Jul 5;181(1-2):151-63
references.pmid: 11476949
references.citation: Nucleic Acids Res. 2004 Dec 01;32(21):6212-7
references.pmid: 15576347
references.citation: Nucleic Acids Res. 2010 Apr;38(7):2355-68
references.pmid: 20047966
references.citation: Cell. 2000 Dec 8;103(6):843-52
references.pmid: 11136970
references.citation: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):4852-7
references.pmid: 17360330
references.citation: Mol Cell Biol. 2009 Jun;29(12):3413-23
references.pmid: 19364822